Generics - Teva Pharmaceutical Industries, Financial

Filter

Popular Filters

Teva 1st-qtr 2014 boosted by new generics

Teva 1st-qtr 2014 boosted by new generics

01-05-2014

Israel generic giant Teva Pharmaceutical Industries reported a 2% rise in revenues to $5.0 billion for…

FinancialGenericsTeva Pharmaceutical Industries

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

Teva’s full year results steady led by Copaxone sales up 8%

Teva’s full year results steady led by Copaxone sales up 8%

07-02-2014

Israel-based Teva Pharmaceutical Industries has released its full year results for 2014 showing that…

CopaxoneEastern EuropeFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva Pharma reaches $718 million tax settlement with Israel State

Teva Pharma reaches $718 million tax settlement with Israel State

12-11-2013

Israel-headquartered global generic drug giant Teva Pharmaceutical Industries has reached an agreement…

FinancialGenericsRest of the WorldTeva Pharmaceutical Industries

Teva results report increase in sales despite flat generic revenues

Teva results report increase in sales despite flat generic revenues

01-11-2013

Still shaken by the sudden resignation of its chief executive this week, Israel-based Teva Pharmaceutical…

FinancialGenericsRest of the WorldTeva Pharmaceutical Industries

Teva Pharma sees slowdown in generic revenues

01-08-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world largest generics firm but with a…

CopaxoneFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva 1st-qtr sales and profits decline

02-05-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) says that first-quarter 2013 net revenue dipped…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Merck & Co to pay $688 million to settle investor law suits; Teva could face $2.1 billion damages

15-02-2013

US pharma giant Merck & Co (NYSE: MRK) said yesterday that it has reached an agreement in principle with…

FinancialGenericsLegalMerck & CoPharmaceuticalProtonixTeva Pharmaceutical IndustriesVytorinZetia

Teva Pharma's 4th-qtr financials just misses forecasts

08-02-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) reported results for the fourth quarter 2012,…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva fleshes out restructuring plan; licenses Xenon pain drug for $376 million

12-12-2012

Teva Pharmaceutical Industries (NYSE: TEVA's new chief executive Jeremy Levin has outlined the company's…

CopaxoneFinancialGenericsLicensingPatentsPharmaceuticalResearchTeva Pharmaceutical IndustriesXenon Pharmaceuticals

Teva Pharma's earnings beat forecasts, but sales lower than expected

02-11-2012

Israel-headquartered Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs maker…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Johnson & Johnson close to settling over Risperdal marketing; SEC probes Teva

06-08-2012

US health care giant Johnson & Johnson (NYSE: JNJ) has reached "an agreement in principle'' with the…

FinancialGenericsInvegaJanssenJohnson & JohnsonLegalMarkets & MarketingNatrecorNorth AmericaPharmaceuticalRisperdalTeva Pharmaceutical Industries

Teva's EPS rockets, helped by higher sales in USA

03-08-2012

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA), the world's largest generic drugs producer…

CephalonFinancialGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

Novartis and Teva announce expansion plans in Russia

05-07-2012

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia's largest…

EuropeFinancialGenericsMarkets & MarketingNovartisPharmaceuticalRT-BiotechpromTeva Pharmaceutical Industries

Mylan settles Provigil litigation with Teva

10-06-2012

US generic major Mylan (Nasdaq: MYL) says that its subsidiary Mylan Pharmaceuticals has resolved all…

CephalonFinancialGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaProvigilTeva Pharmaceutical Industries

Teva lowers full-year 2012 forecasts

25-05-2012

Israel-based generic drug major Teva Pharmaceutical Industries (Nasdaq: TEVA) has provided its current…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Israel'sTeva beats expectations with 40% leap in profit

09-05-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) has reported a robust set of first-quarter…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva Pharma strong sales growth helped by acquisitions

16-02-2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) reported fourth-quarter 2011 results…

CephalonFinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Teva to make massive share buy-back; expects $22 billion sales for 2011

22-12-2011

Israel-based generic drugs giant Teva Pharmaceutical Industries (Nasdaq: TEVA) has announced it plans…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

Parexel

Parexel

Back to top